LUCENTIS sol inj 1.65 mg/0.165ml ser pré 0.165 ml
7680632770019
CH-63277
S01LA04
11.99.0.
Reimbursement limitations:
LUCENTIS2
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) – DMLA, d’une …
1 / 3
google
Details
- Product number
- 6327701
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- Lösung: ranibizumabum 10 mg, histidini hydrochloridum monohydricum, histidinum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Lucentis, Injektionslösung zur intravitrealen Anwendung in Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLU
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 677.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2014
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 63277
- Drug name
- Lucentis, Injektionslösung zur intravitrealen Anwendung in Fertigspritze
- Galenic form
- LSINJ
- ATC Code
- S01LA04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/01/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LUCENTIS sol inj 1.65 mg/0.165ml ser pré 0.165 ml
- Description (DE)
- LUCENTIS Inj Lös 1.65 mg/0.165ml Fertspr 0.165 ml
- Market launch
- 29/01/2014
- Narcotic (BTM)
- No